Sumitomo Life Insurance Co. Cuts Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Sumitomo Life Insurance Co. lessened its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 3.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 10,758 shares of the medical device company’s stock after selling 348 shares during the period. Sumitomo Life Insurance Co.’s holdings in Cooper Companies were worth $989,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Fulton Bank N.A. grew its holdings in shares of Cooper Companies by 3.0% during the 4th quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock worth $342,000 after purchasing an additional 109 shares during the period. Mitchell & Pahl Private Wealth LLC grew its stake in Cooper Companies by 1.5% during the third quarter. Mitchell & Pahl Private Wealth LLC now owns 7,986 shares of the medical device company’s stock worth $881,000 after buying an additional 117 shares during the period. Bleakley Financial Group LLC increased its position in shares of Cooper Companies by 2.1% in the third quarter. Bleakley Financial Group LLC now owns 5,767 shares of the medical device company’s stock worth $636,000 after acquiring an additional 119 shares in the last quarter. MassMutual Private Wealth & Trust FSB raised its stake in shares of Cooper Companies by 15.6% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock valued at $93,000 after acquiring an additional 136 shares during the period. Finally, UMB Bank n.a. lifted its holdings in shares of Cooper Companies by 22.5% during the 4th quarter. UMB Bank n.a. now owns 773 shares of the medical device company’s stock valued at $71,000 after acquiring an additional 142 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have commented on the company. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Citigroup reduced their price target on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research report on Friday, December 6th. Morgan Stanley lowered their price objective on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Friday, December 6th. Wells Fargo & Company boosted their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Finally, StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Four equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Stock Down 0.5 %

Shares of Cooper Companies stock opened at $98.00 on Thursday. The business has a 50-day moving average price of $95.91 and a 200 day moving average price of $99.54. The Cooper Companies, Inc. has a fifty-two week low of $84.76 and a fifty-two week high of $112.38. The firm has a market cap of $19.56 billion, a P/E ratio of 50.26, a P/E/G ratio of 2.41 and a beta of 0.99. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.04. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business’s revenue was up 9.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.87 EPS. On average, sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.